Sutro Biopharma, Inc. - stock earnings
STRO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -49.3 million USD | 16.9 million USD |
| 2023Q2 | -38.5 million USD | 10.4 million USD |
| 2023Q1 | -50.1 million USD | 12.7 million USD |
| 2022Q4 | -37.1 million USD | 8.6 million USD |
| 2022Q3 | -17.8 million USD | 25.1 million USD |
| 2022Q2 | -26.0 million USD | 28.1 million USD |
| 2022Q1 | -39.1 million USD | 5.9 million USD |
| 2021Q4 | -38.1 million USD | 10.7 million USD |
| 2021Q3 | -30.9 million USD | 8.5 million USD |
| 2021Q2 | -6.2 million USD | 28.0 million USD |
| 2021Q1 | -30.4 million USD | 14.7 million USD |
| 2020Q4 | -59.5 million USD | 8.3 million USD |
| 2020Q3 | 17.1 million USD | 17.8 million USD |
| 2020Q2 | 29.9 million USD | 9.5 million USD |
| 2020Q1 | -19.6 million USD | 7.2 million USD |
| 2019Q4 | -14.8 million USD | 11.3 million USD |
| 2019Q3 | -12.9 million USD | 12.3 million USD |
| 2019Q2 | -13.8 million USD | 10.5 million USD |
| 2019Q1 | -1.5 million USD | 19.1 million USD |
| 2018Q4 | -1.5 million USD | 19.1 million USD |
| 2018Q3 | -10.2 million USD | 7.8 million USD |
| 2018Q2 | -11.5 million USD | 5.7 million USD |
| 2018Q1 | -12.0 million USD | 5.8 million USD |
| 2017Q4 | -15.3 million USD | 4.0 million USD |
| 2017Q3 | -1.4 million USD | 17.5 million USD |
| 2017Q2 | 2.9 million USD | 30.2 million USD |
| 2017Q1 | -1.5 million USD | 15.1 million USD |
| 2016Q4 | 1.7 million USD | 59.7 million USD |
STRO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -172.5 million USD | 48.6 million USD |
| 2022 | -119.2 million USD | 67.8 million USD |
| 2021 | -108.7 million USD | 61.9 million USD |
| 2020 | -36.2 million USD | 42.7 million USD |
| 2019 | -55.7 million USD | 42.7 million USD |
| 2018 | -35.3 million USD | 38.4 million USD |
| 2017 | -19.7 million USD | 51.7 million USD |
| 2016 | 1.7 million USD | 59.7 million USD |
STRO
Price: $4.28
52 week price:
Earnings Per Share: -1.78 USD
P/E Ratio: -1.61
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 223541
Market Capitalization: 313.2 million